branded tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Compounded Tirzepatide Injections $100 |

What the New Research Shows Published in Nature Medicine in June 2026, the phase 2 EMBRAZE trial examined the combination of tirzepatide and apitegromab, an investigational monoclonal antibody that selectively inhibits myostatin activation

Semaglutide dose escalation and allodynia prevention While no proven prevention strategy exists specifically for semaglutide-associated allodynia, the dose-dependent nature of the condition suggests that thoughtful dose management may reduce risk

Full Article Ozempic and other GLP-1 agonists have rapidly gained the status of cultural phenomenon over the past few years

Introduction Obesity is recognized by the World Health Organization as the pandemic of the 21 st century

This FDA approval is based on the results of the SURMOUNT-OSA phase 3 clinical trials